The DOI matches its Crossref record.
Autologous stem cell transplantation for systemic lupus erythematosus
Abstract
Systemic lupus erythematosus (SLE) is responsive to treatment with immunosuppressives and steroids, but often pursues a relapsing or refractory course resulting in increasing incapacity and reduced survival. Autologous stem cell transplantation (ASCT) following immunoablative chemotherapy is a newer therapy for autoimmune disease of potential use in severe SLE. A retrospective registry survey was carried out by the European Blood and Marrow Transplant and European League Against Rheumatism (EBMT/EULAR) registry. Data was collected from 53 patients with SLE treated by ASCT in 23 centres. Disease duration before ASCT was 59 (2-155) months (median, range), 44 (83%) were female, and median age was 29 (9-52) years. At the time of ASCT a median of seven American College of Rheumatology (ACR) diagnostic criteria for SLE were present (range 2-10) and 33 (62%) had nephritis. Peripheral blood stem cells were mobilized with cyclophosphamide and granulocyte colony stimulating factor in 93% of cases. Ex vivo CD34 stem cell selection was performed in 42% of patients. Conditioning regimens employed cyclophosphamide in 84%, anti-thymocyte globulin in 76% and lymphoid irradiation in 22%. The mean duration of follow-up after ASCT was 26 (0-78) months. Remission of disease activity (SLEDAI < 3) was seen in 33/50 (66%; 95%CI 52-80) evaluable patients by six months, of which 10/31 (32%; 95%CI 15-50) subsequently relapsed after six (3-40) months. Relapse was associated with negative anti-double stranded DNA (anti-dsDNA) antibodies before ASCT (P = 0.007). There were 12 deaths after 1.5 (0-48) months, of which seven (12%; 95%CI 3-21) were related to the procedure. Mortality was associated with a longer disease course before ASCT (P = 0.036). In conclusion, this registry study demonstrates the efficacy of ASCT for remission induction of refractory SLE, although mortality appeared high. The safety of this procedure is likely to be improved by patient selection and choice of conditioning regimen. The return of disease activity in one-third of patients might be reduced by long-term immunosuppressive therapy post-ASCT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cyclophosphamide and cancer: golden anniversary
Emadi, A., Jones, R. J., & Brodsky, R. A. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.146 · Cited by 1,050
Anders, H.-J., Saxena, R., Zhao, M.-H., Parodis, I., Salmon, J. E., & Mohan, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0141-9 · Cited by 958
Farge, D., Labopin, M., Tyndall, A., Fassas, A., Mancardi, G. L., Van Laar, J., Ouyang, J., Kozak, T., Moore, J., Kotter, I., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.013458 · Cited by 364
Self-citation(PDWP), O. B. O. T. E. A. D. W. P. (. A. P. D. W. P., Snowden, J. A., Saccardi, R., Allez, M., Ardizzone, S., Arnold, R., Cervera, R., Denton, C., Hawkey, C., Labopin, M., et al. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2011.185 · Cited by 328
Self-citationAlexander, T., Thiel, A., Rosen, O., Massenkeil, G., Sattler, A., Kohler, S., Mei, H., Radtke, H., Gromnica-Ihle, E., Burmester, G.-R., et al. (2009) · Blood · doi:10.1182/blood-2008-07-168286 · Cited by 316
Self-citation
Metadata
- Authors
- Jayne, D., Passweg, J., Marmont, A., Farge, D., Zhao, X., Arnold, R., Hiepe, F., Lisukov, I., Musso, M., Ou-Yang, J., Marsh, J., Wulffraat, N., Besalduch, J., Bingham, S. J., Emery, P., Brune, M., Fassas, A., Faulkner, L., Ferster, A., Fiehn, C., Fouillard, L., Geromin, A., Greinix, H., Rabusin, M., Saccardi, R., Schneider, P., Zintl, F., Gratwohl, A., Tyndall, A., European Group for Blood and Marrow Transplantation, & European League Against Rheumatism Registry
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2004-03-01
- Volume
- 13
- Issue
- 3
- Pages
- 168-176
- ISSN
- 0961-2033 (ISSN-L)
- OpenAlex
- W4243514558
- Cited by
- 184
- References
- 0
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autologous stem cell transplantation for systemic lupus erythematosus. https://app.cochat.ai/papers/10.1191/0961203304lu525oa
- The paper
- Jayne, D., Passweg, J., Marmont, A., Farge, D., Zhao, X., Arnold, R., Hiepe, F., Lisukov, I., Musso, M., Ou-Yang, J., Marsh, J., Wulffraat, N., Besalduch, J., Bingham, S. J., Emery, P., Brune, M., Fassas, A., Faulkner, L., Ferster, A., . . . European League Against Rheumatism Registry. (2004). Autologous stem cell transplantation for systemic lupus erythematosus. Lupus. https://doi.org/10.1191/0961203304lu525oa
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.